14 results
8-K
EX-10.1
BLPH
Bellerophon Therapeutics, Inc.
30 Mar 20
Bellerophon Announces $15.3 Million Registered Direct Offering Priced At-the-Market
4:09pm
or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its
8-K
EX-1.1
cwc00yl4
23 Jan 19
Bellerophon Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
5:05pm
10-K
se8sm
31 Mar 15
Annual report
12:00am
424B4
9cvykhn4zc3pr
13 Feb 15
Prospectus supplement with pricing info
12:00am
S-1
r28wp0tt03g v625262b
13 Jan 15
IPO registration
12:00am
DRS/A
k4ts8 mrsjtykl0soo
21 Nov 14
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next